Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse.

Chung E, Ji Y, Sun Y, Kascsak RJ, Kascsak RB, Mehta PD, Strittmatter SM, Wisniewski T.

BMC Neurosci. 2010 Oct 14;11:130. doi: 10.1186/1471-2202-11-130.

PMID:
20946660
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Anti-PrP Mab 6D11 suppresses PrP(Sc) replication in prion infected myeloid precursor line FDC-P1/22L and in the lymphoreticular system in vivo.

Sadowski MJ, Pankiewicz J, Prelli F, Scholtzova H, Spinner DS, Kascsak RB, Kascsak RJ, Wisniewski T.

Neurobiol Dis. 2009 May;34(2):267-78.

PMID:
19385058
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Accelerated prion disease pathogenesis in Toll-like receptor 4 signaling-mutant mice.

Spinner DS, Cho IS, Park SY, Kim JI, Meeker HC, Ye X, Lafauci G, Kerr DJ, Flory MJ, Kim BS, Kascsak RB, Wisniewski T, Levis WR, Schuller-Levis GB, Carp RI, Park E, Kascsak RJ.

J Virol. 2008 Nov;82(21):10701-8. doi: 10.1128/JVI.00522-08. Epub 2008 Aug 20.

PMID:
18715916
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.

Pankiewicz J, Prelli F, Sy MS, Kascsak RJ, Kascsak RB, Spinner DS, Carp RI, Meeker HC, Sadowski M, Wisniewski T.

Eur J Neurosci. 2006 May;23(10):2635-47.

PMID:
16817866
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk